Prognostic potential of baseline HRQoL in advanced and metastatic renal cell carcinoma
Gruenwald V, Goebell P, Schostak M, Welslau M, Doehn C, Degenkolbe E, Ehness R, Ahrens K, Boegemann M (2022)
Publication Type: Conference contribution
Publication year: 2022
Journal
Publisher: KARGER
City/Town: BASEL
Pages Range: 219-219
Conference Proceedings Title: ONCOLOGY RESEARCH AND TREATMENT
Authors with CRIS profile
Involved external institutions
Universitätsklinikum Essen
Germany (DE)
Otto-von-Guericke-Universität Magdeburg
Germany (DE)
Klinikum Aschaffenburg - Alzenau
Germany (DE)
Urologikum Lübeck
Germany (DE)
Novartis AG
Switzerland (CH)
APOGEPHA Arzneimittel GmbH
Germany (DE)
Universitätsklinikum Münster
Germany (DE)
Germany (DE)
Otto-von-Guericke-Universität Magdeburg
Germany (DE)
Klinikum Aschaffenburg - Alzenau
Germany (DE)
Urologikum Lübeck
Germany (DE)
Novartis AG
Switzerland (CH)
APOGEPHA Arzneimittel GmbH
Germany (DE)
Universitätsklinikum Münster
Germany (DE)
How to cite
APA:
Gruenwald, V., Goebell, P., Schostak, M., Welslau, M., Doehn, C., Degenkolbe, E.,... Boegemann, M. (2022). Prognostic potential of baseline HRQoL in advanced and metastatic renal cell carcinoma. In ONCOLOGY RESEARCH AND TREATMENT (pp. 219-219). BASEL: KARGER.
MLA:
Gruenwald, Viktor, et al. "Prognostic potential of baseline HRQoL in advanced and metastatic renal cell carcinoma." Proceedings of the ONCOLOGY RESEARCH AND TREATMENT BASEL: KARGER, 2022. 219-219.
BibTeX: Download